Anti-metastasis therapy: MiRNA-9600 increases the expression of tumor suppressor PTEN and inhibits proliferation, invasion and metastasis of cancer cells via down regulation of its target gene,21/November/2015, 10.38 am

Molecular therapy for Metabolic disorders: MiRNA-183 increases liver-X-receptor expression, protects aganist diet-induced weight-gain, and increases insulin-secreting cell mass and function via down regulation of its target genes, 20/November/2016, 10.30 am
November 20, 2016
Molecular therapy for Metabolic disorders: MiRNA-208-3p increases (LXR)-α expression, insulin-secreting cell mass and function via down regulation of its target genes, 21/November/2016, 11.04 am
November 21, 2016
Show all

Research findings to Therapeutic opportunity: 

The study presented here suggests that MiRNA-9600, by decreasing the expression of its target genes, it may increase the expression of tumor suppressor PTEN.

price-2

Thereby, it may inhibit cell proliferation, increase drug sensitivity, promote apoptosis and inhibit cancer progression. Thus, pharmacological formulations encompassing “MiRNA-9600 activators” may be used to inhibit the progression of invasive tumors.


Details of the research findings

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Undisclosed information: How MiRNA-9600  increases the expression of metastasis suppressor PTEN

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/


References

CitationBoominathan, L., Anti-metastasis therapy: MiRNA-9600 increases the expression of tumor suppressor PTEN and inhibits proliferation, invasion and metastasis of cancer cells via down regulation of its target gene,21/November/2015, 10.38 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.